Bio-Techne Corp (FRA:TE1)
€ 76.5 1 (1.32%) Market Cap: 11.96 Bil Enterprise Value: 12.28 Bil PE Ratio: 65.48 PB Ratio: 6.45 GF Score: 92/100

Bio-Techne Corp at Goldman Sachs Global Healthcare Conference Transcript

Jun 11, 2019 / 08:20PM GMT
Release Date Price: €46.56 (+1.85%)
Patrick B. Donnelly
Goldman Sachs Group Inc., Research Division - Equity Analyst

We can get started. Thanks for being here. I'm Patrick Donnelly, the tools and diagnostics analyst here at Goldman. Happy to have Chuck and Jim, the CEO and CFO from Bio-Techne, here with us today. It's open Q&A, so feel free if you have any questions. Just raise your hands, I'll call out -- call you out.

Questions & Answers

Patrick B. Donnelly
Goldman Sachs Group Inc., Research Division - Equity Analyst

But Chuck, maybe just to start, I'll open it up to you just to kind of talk through the most recent results. Obviously, encouraging recovery from ACD, which you guys projected. But yes, maybe just recap the most recent results and we can dive in from there.

Charles R. Kummeth
Bio-Techne Corporation - CEO, President & Director

Sure. It was a great quarter, our best quarter, I guess, in the 6 years I've been there. So we did 14-plus percent organic growth. Long time coming. We've been tracking from 0 up to the -- this

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot